|
PPP1R3D expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.680900E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.882000E-03 |
| Normal-vs-Stage2 |
2.930400E-01 |
| Normal-vs-Stage3 |
5.797300E-04 |
| Normal-vs-Stage4 |
1.038820E-03 |
| Stage1-vs-Stage2 |
2.523400E-01 |
| Stage1-vs-Stage3 |
2.874400E-02 |
| Stage1-vs-Stage4 |
5.764200E-02 |
| Stage2-vs-Stage3 |
1.293840E-02 |
| Stage2-vs-Stage4 |
2.139500E-02 |
| Stage3-vs-Stage4 |
8.140200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.809900E-04 |
| Normal-vs-AfricanAmerican |
3.408200E-01 |
| Normal-vs-Asian |
7.258200E-02 |
| Caucasian-vs-AfricanAmerican |
8.847900E-02 |
| Caucasian-vs-Asian |
1.601400E-01 |
| AfricanAmerican-vs-Asian |
5.887400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.236700E-03 |
| Normal-vs-Female |
6.016900E-03 |
| Male-vs-Female |
9.423600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.802700E-03 |
| Normal-vs-Age(41-60Yrs) |
4.475700E-03 |
| Normal-vs-Age(61-80Yrs) |
1.035770E-02 |
| Normal-vs-Age(81-100Yrs) |
4.096100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.455800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.166400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.211600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.736400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.934600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.421200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.435400E-03 |
| Classical-VS-Follicular |
1.572060E-02 |
| Classical-VS-Other |
5.628400E-01 |
| Classical-VS-Normal |
7.164600E-03 |
| Tall-VS-Follicular |
4.39359999999667E-05 |
| Tall-VS-Other |
4.909400E-01 |
| Tall-VS-Normal |
4.07829999999887E-05 |
| Follicular-VS-Other |
2.294800E-01 |
| Follicular-VS-Normal |
4.455800E-01 |
| Other-VS-Normal |
1.383600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.557300E-03 |
| Normal-vs-N1 |
1.774400E-04 |
| N0-vs-N1 |
1.280080E-02 |
|
|
